Showing results (601-610 of 628) with videos related to

Sort By:
Pageof 63
Cancer Chemotherapy and Pharmacology|April 22, 2020
Intravenous 5-fluoro-2'-deoxycytidine administered with tetrahydrouridine increases the proportion of p16-expressing circulating tumor cells in patients with advanced solid tumorsGeraldine O 'Sullivan Coyne, Lihua Wang, Jennifer Zlott, et al.
Pharmacoepidemiology and Drug Safety|November 25, 2024
Determining Line of Therapy from Real-World Data in Non-Small Cell Lung CancerConnor B Grady, Wei-Ting Hwang, Joshua E Reuss, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 8, 2024
Changes In Serum CXCL13 Levels Are Associated With Outcomes of Colorectal Cancer Patients Undergoing First-Line Oxaliplatin-Based TreatmentSara Cabrero-de Las Heras, Xavier Hernández-Yagüe, Andrea González, et al.
Clinical and Translational Gastroenterology|September 27, 2023
TRAV26-2 T-Cell Receptor Expression Is Associated With Mucosal Lymphocyte Response to Wheat Proteins in Patients With Functional DyspepsiaGrace L Burns, Michael Potter, Andrea Mathe, et al.
JAMIA Open|May 14, 2023
A metadata framework for computational phenotypesMatthew Spotnitz, Nripendra Acharya, James J Cimino, et al.
Nature|September 3, 2011
Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humansCaroline J Breitbach, James Burke, Derek Jonker, et al.
Thrombosis Research|November 14, 2025
Venous thrombosis in lung cancer compared with other tumors: results from the TESEO-SEOM registryClaudia Iglesias-Perez, Paula Jimenez-Fonseca, Javier López Robles, et al.
JTO Clinical and Research Reports|January 6, 2025
Changing Treatment and Metastatic Disease Patterns in Patients with EGFR Mutated NSCLC: An Academic Thoracic Medical Investigator's Consortium Registry AnalysisMargaret Stalker, Connor B Grady, Alex Watts, et al.
Lung Cancer (Amsterdam, Netherlands)|April 22, 2025
Osimertinib vs. Afatinib in 1L therapy of atypical EGFR-mutated metastatic non-small cell lung cancer (mNSCLC): A multi-institution, real-world survival analysisAdam Barsouk, Omar Elghawy, Alex Watts, et al.
JTO Clinical and Research Reports|August 19, 2024
Characteristics of Long-Term Survivors With EGFR-Mutant Metastatic NSCLCWilliam Tompkins, Connor B Grady, Wei-Ting Hwang, et al.
Pageof 63